Lista de obras -

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

artículo científico publicado en 2007

Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset ⬇️

artículo científico publicado el 23 de marzo de 2011

Autoantibodies in type 1 diabetes

artículo científico publicado en 2008

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups

artículo científico publicado en 2005

Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab

artículo científico publicado en 2011

Case report: an 11-year-old girl with tetany

artículo científico publicado en 2002

Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions

artículo científico publicado en 2008

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up

artículo científico publicado en 2004

Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening

artículo científico publicado en 2006

Comparison of insulin autoantibody: polyethylene glycol and micro-IAA 1-day and 7-day assays

artículo científico publicado en 2009

Compounding risk for hypoglycemia: type 1 diabetes and Addison's disease

artículo científico publicado en 2012

Congenital adrenal hyperplasia and the second newborn screen

scientific article published on 12 February 2013

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset

artículo científico publicado en 2009

Dominant Suppression of Addison's Disease Associated with HLA-B15 ⬇️

artículo científico publicado el 11 de mayo de 2011

Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study

artículo científico publicado en 2007

Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population

artículo científico publicado en 2004

Extreme genetic risk for type 1A diabetes

artículo científico publicado en 2006

Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes

artículo científico publicado en 2005

Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease

artículo científico publicado en 2010

Heterophile antibodies masquerade as interferon-alpha in subjects with new-onset type 1 diabetes

artículo científico publicado en 2004

Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.

artículo científico publicado en 2009

Hypo and Hyper: Common Pediatric Endocrine and Metabolic Emergencies

artículo científico

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization

artículo científico publicado en 2008

Natural evolution, prediction, and prevention of type 1 diabetes in youth

scientific article published on January 2008

Polyendocrine autoimmunity

artículo científico publicado en 2005

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing

artículo científico publicado en 2007

Predicting the onset of Addison’s disease: ACTH, renin, cortisol and 21‐hydroxylase autoantibodies ⬇️

artículo científico publicado el 1 de mayo de 2012

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

artículo científico publicado en 2004

Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity

artículo científico publicado en 2006

Prevention strategies for type 1 diabetes

artículo científico publicado en 2006

Primary prevention of type 1A diabetes: are we there yet?

artículo científico publicado en 2007

Translating mucosal antigen based prevention of autoimmune diabetes to human.

artículo científico publicado en 2008

Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening

artículo científico publicado en 2008

Type 1 diabetes: chronic progressive autoimmune disease.

artículo científico publicado en 2008

Using the electronic medical record to improve education in patients at risk for adrenal insufficiency

artículo científico publicado en 2010

Lista de obras de

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset ⬇️

Autoantibodies in type 1 diabetes

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups

Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab

Case report: an 11-year-old girl with tetany

Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up

Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening

Comparison of insulin autoantibody: polyethylene glycol and micro-IAA 1-day and 7-day assays

Compounding risk for hypoglycemia: type 1 diabetes and Addison's disease

Congenital adrenal hyperplasia and the second newborn screen

Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset

Dominant Suppression of Addison's Disease Associated with HLA-B15 ⬇️

Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study

Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population

Extreme genetic risk for type 1A diabetes

Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes

Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease

Heterophile antibodies masquerade as interferon-alpha in subjects with new-onset type 1 diabetes

Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes.

Hypo and Hyper: Common Pediatric Endocrine and Metabolic Emergencies

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization

Natural evolution, prediction, and prevention of type 1 diabetes in youth

Polyendocrine autoimmunity

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing

Predicting the onset of Addison’s disease: ACTH, renin, cortisol and 21‐hydroxylase autoantibodies ⬇️

Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity

Prevention strategies for type 1 diabetes

Primary prevention of type 1A diabetes: are we there yet?

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening

Type 1 diabetes: chronic progressive autoimmune disease.

Using the electronic medical record to improve education in patients at risk for adrenal insufficiency